Seek Returns

AAPL vs. ABBV: Apple vs. AbbVie Stock Comparison

How do Apple (AAPL) and AbbVie (ABBV) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Apple (AAPL) is classified in the Information Technology sector (Technology Hardware & Equipment), whereas AbbVie (ABBV) belongs to Health Care (Pharmaceuticals, Biotechnology & Life Sciences) — their GICS classifications point to very different parts of the market.

Company profile comparison for Apple (AAPL) and AbbVie (ABBV)
Profile ItemAAPLABBV
NameApple Inc.AbbVie Inc.
Country/RegionUnited StatesUnited States
GICS SectorInformation TechnologyHealth Care
GICS Industry GroupTechnology Hardware & EquipmentPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryTechnology Hardware, Storage & PeripheralsBiotechnology
GICS Sub-IndustryTechnology Hardware, Storage & PeripheralsBiotechnology
Market Capitalization4,975.38 billion USD514.92 billion USD
CurrencyUSDUSD
ExchangeNasdaqNYSE
Listing DateDecember 12, 1980January 2, 2013
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

AAPL
ABBV
GSPC
Loading price history…
Apple (AAPL) vs. AbbVie (ABBV), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Apple (AAPL) and AbbVie (ABBV). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Apple (AAPL) and AbbVie (ABBV). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Apple (AAPL) and AbbVie (ABBV)
MetricAAPLABBV
Total Return (1Y)31.02%37.33%
Total Return (3Y, Annualized)24.87%32.74%
Total Return (5Y, Annualized)18.93%24.73%

Risk Profile

Drawdown History

AAPL
ABBV
GSPC
Loading price history…
Apple (AAPL) vs. AbbVie (ABBV), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Apple (AAPL) and AbbVie (ABBV). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Apple (AAPL) and AbbVie (ABBV)
MetricAAPLABBV
Volatility (1Y, Annualized)24.99%25.65%
Beta (5Y)1.080.21
Max Drawdown (5Y)-33.36%-21.92%
Avg. Volume (3M)42.44M4.76M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
AAPL and ABBV are plotted by 1-year volatility (risk) and 1-year return. Each dashed Capital Allocation Line uses that stock's own industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Apple (AAPL) and AbbVie (ABBV)
MetricAAPLABBV
Sharpe Ratio (1Y)1.071.29
Sortino Ratio (1Y)1.582.02

Profitability

ROE (TTM)

Capital efficiency shows on one side only: Apple (AAPL) earns 142.26% on shareholders’ equity, ranked against its industry; AbbVie (ABBV) has no ROE this period.

AAPL

Technology Hardware & Equipment industry group

142.26%

AAPL
142.26%
Max
42.47%
Q3
19.13%
Median
11.00%
Q1
1.63%
Min
-20.62%

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
ABBV
--
Loading chart…
Apple (AAPL) vs. AbbVie (ABBV): ABBV does not report ROE, so it has no value marker; AAPL is benchmarked against the Technology Hardware & Equipment industry group.

Net Margin (TTM)

For every dollar of sales, both Apple (AAPL) at 27.60% and AbbVie (ABBV) at 15.67% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

AAPL

Technology Hardware & Equipment industry group

27.60%

AAPL
27.60%
Max
27.60%
Q3
11.66%
Median
4.08%
Q1
0.00%
Min
-11.02%

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

15.67%

Max
18.05%
ABBV
15.67%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Loading chart…
Apple (AAPL) vs. AbbVie (ABBV): A comparison of their net margin against their respective Technology Hardware & Equipment and Pharmaceuticals, Biotechnology & Life Sciences industry group benchmarks.

Operating Margin (TTM)

Both Apple (AAPL) at 31.13% and AbbVie (ABBV) at 39.59% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

AAPL

Technology Hardware & Equipment industry group

31.13%

Max
36.27%
AAPL
31.13%
Q3
18.36%
Median
8.84%
Q1
1.46%
Min
-21.39%

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

39.59%

Max
83.12%
ABBV
39.59%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
Apple (AAPL) vs. AbbVie (ABBV): A comparison of their operating margin against their respective Technology Hardware & Equipment and Pharmaceuticals, Biotechnology & Life Sciences industry group benchmarks.

Profitability Metrics

Profitability metrics for Apple (AAPL) and AbbVie (ABBV)
MetricAAPLABBV
ROE (TTM)142.26%--
ROA (TTM)25.87%10.74%
Net Margin (TTM)27.60%15.67%
Operating Margin (TTM)31.13%39.59%
Gross Margin (TTM)48.79%73.72%

Growth

Revenue Growth

Both Apple (AAPL) at 15.06% and AbbVie (ABBV) at 8.57% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Loading chart…
Apple (AAPL) vs. AbbVie (ABBV): A comparison of their Revenue Growth across different time periods.

EPS Growth

Both Apple (AAPL) at 20.38% and AbbVie (ABBV) at -0.84% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.

Loading chart…
Apple (AAPL) vs. AbbVie (ABBV): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Apple (AAPL) and AbbVie (ABBV)
MetricAAPLABBV
Revenue Growth (YoY)15.06%8.57%
Revenue Growth (3Y CAGR)7.70%1.75%
EPS Growth (YoY)20.38%-0.84%
EPS Growth (3Y CAGR)13.57%-29.03%

Financial Strength

Current Ratio (MRQ)

Both Apple (AAPL) at 1.02 and AbbVie (ABBV) at 0.87 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

AAPL

Technology Hardware & Equipment industry group

1.02

Max
5.34
Q3
3.02
Median
1.95
Q1
1.32
AAPL
1.02
Min
0.17

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.87

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
ABBV
0.87
Min
0.10
Loading chart…
Apple (AAPL) vs. AbbVie (ABBV): A comparison of their current ratio against their respective Technology Hardware & Equipment and Pharmaceuticals, Biotechnology & Life Sciences industry group benchmarks.

Debt / Equity (MRQ)

Only one side’s leverage can be read here: Apple (AAPL) carries debt-to-equity ratio of 0.84 against its industry range, while AbbVie (ABBV) reports no figure this period.

AAPL

Technology Hardware & Equipment industry group

0.84

Max
1.76
AAPL
0.84
Q3
0.78
Median
0.24
Q1
0.04
Min
0.01

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
1.42
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00
ABBV
--
Loading chart…
Apple (AAPL) vs. AbbVie (ABBV): ABBV does not report debt-to-equity ratio, so it has no value marker; AAPL is benchmarked against the Technology Hardware & Equipment industry group.

Financial Strength Metrics

Financial strength metrics for Apple (AAPL) and AbbVie (ABBV)
MetricAAPLABBV
Current Ratio (MRQ)1.020.87
Debt / Equity (MRQ)0.84--
Net Debt / EBITDA0.222.21

Dividends

Dividend Yield (TTM)

Apple (AAPL) at 0.31% pays an industry-typical yield; AbbVie (ABBV) at 2.40% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.

AAPL

Technology Hardware & Equipment industry group

0.31%

Max
0.73%
Q3
0.31%
AAPL
0.31%
Median
0.00%
Q1
0.00%
Min
0.00%

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.40%

ABBV
2.40%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Apple (AAPL) vs. AbbVie (ABBV): A comparison of their dividend yield against their respective Technology Hardware & Equipment and Pharmaceuticals, Biotechnology & Life Sciences industry group benchmarks.

Dividend Payout Ratio (TTM)

AbbVie (ABBV) reports payout ratio above 100% at 117.35%, meaning dividends exceeded current-period earnings and sustainability needs extra context. Meanwhile Apple (AAPL) reports 11.80%, ranking against industry peers normally.

AAPL

Technology Hardware & Equipment industry group

11.80%

Max
32.27%
Q3
14.48%
AAPL
11.80%
Median
0.00%
Q1
0.00%
Min
0.00%

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

117.35%

ABBV
117.35%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Apple (AAPL) vs. AbbVie (ABBV): A comparison of their payout ratio against their respective Technology Hardware & Equipment and Pharmaceuticals, Biotechnology & Life Sciences industry group benchmarks.

Dividend Metrics

Dividend metrics for Apple (AAPL) and AbbVie (ABBV)
MetricAAPLABBV
Dividend Yield (TTM)0.31%2.40%
Dividend Payout Ratio (TTM)11.80%117.35%

Valuation

P/E Ratio (TTM)

Apple (AAPL) at 38.13 is near its industry’s usual P/E ratio, while AbbVie (ABBV) at 50.05 sits in the richer quartile — ABBV needs stronger growth or earnings quality to justify the premium.

AAPL

Technology Hardware & Equipment industry group

38.13

Max
69.48
Q3
41.02
AAPL
38.13
Median
26.39
Q1
19.36
Min
6.07

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

50.05

Max
85.34
ABBV
50.05
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07
Loading chart…
Apple (AAPL) vs. AbbVie (ABBV): A comparison of their P/E ratio against their respective Technology Hardware & Equipment and Pharmaceuticals, Biotechnology & Life Sciences industry group benchmarks.

P/S Ratio (TTM)

AbbVie (ABBV) at 7.80 is priced about in line with its industry on P/S ratio, while Apple (AAPL) at 10.39 sits in the pricier quartile — AAPL costs more per dollar of sales.

AAPL

Technology Hardware & Equipment industry group

10.39

Max
11.30
AAPL
10.39
Q3
5.82
Median
2.56
Q1
1.05
Min
0.00

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

7.80

Max
58.18
Q3
25.77
ABBV
7.80
Median
7.30
Q1
3.01
Min
0.01
Loading chart…
Apple (AAPL) vs. AbbVie (ABBV): A comparison of their P/S ratio against their respective Technology Hardware & Equipment and Pharmaceuticals, Biotechnology & Life Sciences industry group benchmarks.

P/B Ratio (MRQ)

AbbVie (ABBV) reports a negative P/B ratio of -112.34, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Apple (AAPL) reports 44.39, ranking against industry peers normally.

AAPL

Technology Hardware & Equipment industry group

44.39

AAPL
44.39
Max
10.75
Q3
5.52
Median
3.17
Q1
1.79
Min
0.33

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

-112.34

Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59
ABBV
-112.34
Loading chart…
Apple (AAPL) vs. AbbVie (ABBV): A comparison of their P/B ratio against their respective Technology Hardware & Equipment and Pharmaceuticals, Biotechnology & Life Sciences industry group benchmarks.

Valuation Metrics

Valuation metrics for Apple (AAPL) and AbbVie (ABBV)
MetricAAPLABBV
P/E Ratio (TTM)38.1350.05
P/S Ratio (TTM)10.397.80
P/B Ratio (MRQ)44.39-112.34
Free Cash Flow Yield (TTM)2.12%3.44%